Financhill
Back

Acumen Pharmaceuticals Stock Predictions

Acumen Pharmaceuticals Stock Forecast

  • Is Acumen Pharmaceuticals Stock Undervalued?
    The current Acumen Pharmaceuticals [ABOS] share price is $1.79. The Score for ABOS is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
  • ABOS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Acumen Pharmaceuticals Stock Go Up Next Year?

Data Unavailable

Acumen Pharmaceuticals Stock Rating

Data Unavailable

Acumen Pharmaceuticals Stock Price History

Is ABOS stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABOS is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
acumenpharm.com

52-Week Data

52-Week High:
5.09
52-Week Low:
1.72

Prediction Charts

Market Cap:
107.5M
Price in USD:
1.79
Volume:
363.2K
Beta:
-0.07

Technical Analysis

SMA50:
2.46
SMA100:
2.51
SMA200:
2.87
52-Wk Change:
-49.86%

Stock Predictions

  • Is Acumen Pharmaceuticals stock public?
    Yes, Acumen Pharmaceuticals is a publicly traded company.
  • What is the Acumen Pharmaceuticals stock quote today?
    The Acumen Pharmaceuticals stock price is 1.79 USD today.
  • How to buy Acumen Pharmaceuticals stock online?
    You can buy Acumen Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-5 2.25 2.12 2.27 2.11
Dec-6 2.12 2.16 2.19 2.12
Dec-9 2.15 2.25 2.29 2.15
Dec-10 2.22 2.17 2.24 2.15
Dec-11 2.15 2.18 2.24 2.05
Dec-12 2.15 2.07 2.24 2.05
Dec-13 2.09 2.03 2.09 1.95
Dec-16 1.99 1.97 2.02 1.92
Dec-17 1.97 1.96 2.03 1.91
Dec-18 1.95 1.79 1.97 1.76
Dec-19 1.84 1.80 1.87 1.72
Dec-20 1.78 1.84 1.86 1.75
Dec-23 1.85 1.77 1.85 1.76
Dec-24 1.80 1.79 1.83 1.73

Acumen Pharmaceuticals Earnings

Data Unavailable

Acumen Pharmaceuticals Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.34 per share, and a decrease next year of $0.21 per share.

* Acumen Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.